Brain+ A/S
Quotes
Share:
Subscribe:
news.cision.com
/
Brain+ A/S
/
Positive results from the first of four clinical studies to evaluate Brain+’ Starry Night cognitive test for early detection of Alzheimer’s Disease
/
1 B EN RGB
1 B EN RGB
Thu, Feb 03, 2022 09:00 CET
new
Low resolution
Medium resolution
Original resolution
Subscribe
Related Releases
Brain+ A/S announces that its board and management provide commitments to cover 13.7% of the warrants of series TO 4
Tue, Sep 17, 2024 10:46 CET
Brain+ is set to deliver on an ambitious UK commercial plan to reach recurring revenue of DKK 7-8 million by 2025 and DKK 25-27 million by 2027
Fri, Sep 13, 2024 10:33 CET
Brain+ A/S announces the exercise price for its warrants of series TO 4
Fri, Sep 13, 2024 09:08 CET